It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
NOABSTRACT
Recent studies show that, deimination, one of the post-translational modifications, is associated with the neuro-degenerative disease process. Peptidyl arginine deiminases (PADs) catalyze deimination, PAD2 is particularly active in the central nervous system. This study aimed to examine the changes in proteins regarding deimination by inducing inflammation with lipopolysaccharide (LPS) in the BV2 microglial cell line and observe the changes in cytokines.
LPS was applied to the microglial cell line. The change in Interleukin-1β (IL-1β) was observed by enzyme linked immunosorbent assay (ELISA). Western blotting with F95 antibody was performed to identify deimine proteins. To determine whether C-reactive protein (CRP) was changed, immunoprecipitation with anti-CRP antibody or not was followed by western blotting with F95 antibody. Real-time polymerase chain reaction (RT-PCR) was performed to determine the change in PAD2 and CRP expression levels.
A significant increase in IL-1β due to inflammation was observed in microglia. An increase in the proteins subjected to deimination was observed by Western blot method and it was determined that CRP was deiminated. A statistically significant decrease in PAD2 expression level was observed by RT-PCR.
In the present study, an increase in IL 1-β levels and the amount of deimination protein was observed as a result of inflammation.This result confirms that there is a connection between neurodegeneration and deimination. This study is the first to show that CRP is one of the deiminated protein candidates as a result of inflammation in microglia.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Medical Biochemistry, Selcuk University, Konya, Turkey
2 Medical Biochemistry, Necmettin Erbakan University, Faculty of Medicine, Konya, Turkey
3 Medical Genetics, Selçuk University, Konya, Faculty of Medicine, Turkey
4 Medical Biochemistry, Konya City Hospital, Konya, Turkey